Title of article :
Novel tricyclic azepine derivatives: Biological evaluation of pyrimido[4,5-b]-1,4-benzoxazepines, thiazepines, and diazepines as inhibitors of the epidermal growth factor receptor tyrosine kinase
Author/Authors :
Leon Smith II، نويسنده , , Wai C. Wong، نويسنده , , Alexander S. Kiselyov، نويسنده , , Sabina Burdzovic-Wizemann، نويسنده , , Yunyu Mao، نويسنده , , Yongjiang Xu، نويسنده , , Matthew A.J. Duncton، نويسنده , , Ki Kim، نويسنده , , Evgueni L. Piatnitski، نويسنده , , Jacqueline F. Doody، نويسنده , , Ying Wang، نويسنده , , Robin L. Rosler، نويسنده , , Daniel Milligan، نويسنده , , John Columbus، نويسنده , , Chris Balagtas، نويسنده , , Sui Ping Lee، نويسنده , , Andrey Konovalov، نويسنده , , Yaron R. Hadari، نويسنده ,
Abstract :
Novel tricyclic derivatives containing an oxazepine, thiazepine, or diazepine ring were studied for their EGFR tyrosine kinase inhibitory activity. While the oxazepines were in general more potent than thiazepines, the diazepines displayed somewhat different structure–activity relationships. Moreover, the diazepines, in contrast to the oxazepines, showed appreciable inhibitory activity against the KDR tyrosine kinase. Furthermore, both oxazepines and diazepines demonstrated significant ability to inhibit autophosphorylation of EGFR in DiFi cells (generally, IC50 values in the single-digit micromolar to submicromolar range).
Keywords :
Thiazepine , kinase inhibitor , Oxazepine , epidermal growth factor receptor , Diazepine